Schroder Investment Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $311M | Buy |
12,896,296
+300,462
| +2% | +$7.86M | 0.22% | 97 |
|
|
2026
Q1 | $354M | Buy |
12,595,834
+244,348
| +2% | +$6.51M | 0.29% | 73 |
|
|
2025
Q4 | $308M | Sell |
12,351,486
-25,252
| -0.2% | -$637K | 0.23% | 83 |
|
|
2025
Q3 | $315M | Sell |
12,376,738
-203,688
| -2% | -$5.03M | 0.25% | 79 |
|
|
2025
Q2 | $305M | Buy |
12,580,426
+2,214,311
| +21% | +$51.6M | 0.26% | 82 |
|
|
2025
Q1 | $263M | Buy |
10,366,115
+392,805
| +4% | +$10.3M | 0.27% | 83 |
|
|
2024
Q4 | $265M | Buy |
9,973,310
+1,193,722
| +14% | +$32.4M | 0.25% | 77 |
|
|
2024
Q3 | $254M | Buy |
8,779,588
+1,613,101
| +23% | +$47.1M | 0.26% | 80 |
|
|
2024
Q2 | $201M | Buy |
7,166,487
+1,000,764
| +16% | +$27.6M | 0.22% | 88 |
|
|
2024
Q1 | $171M | Buy |
6,165,723
+515,637
| +9% | +$14.3M | 0.2% | 98 |
|
|
2023
Q4 | $163M | Buy |
5,650,086
+698,526
| +14% | +$21.1M | 0.21% | 92 |
|
|
2023
Q3 | $164M | Sell |
4,951,560
-1,308,159
| -21% | -$46.3M | 0.24% | 79 |
|
|
2023
Q2 | $230M | Sell |
6,259,719
-705,682
| -10% | -$27.5M | 0.33% | 62 |
|
|
2023
Q1 | $284M | Sell |
6,965,401
-2,963,147
| -30% | -$128M | 0.42% | 47 |
|
|
2022
Q4 | $509M | Sell |
9,928,548
-624,543
| -6% | -$29.9M | 0.81% | 23 |
|
|
2022
Q3 | $462M | Sell |
10,553,091
-1,307,392
| -11% | -$63.5M | 0.76% | 22 |
|
|
2022
Q2 | $622M | Buy |
11,860,483
+54,484
| +0.5% | +$2.78M | 0.95% | 13 |
|
|
2022
Q1 | $611M | Buy |
11,805,999
+1,269,340
| +12% | +$65.9M | 0.81% | 21 |
|
|
2021
Q4 | $622M | Buy |
10,536,659
+1,567,089
| +17% | +$77.6M | 0.81% | 20 |
|
|
2021
Q3 | $386M | Sell |
8,969,570
-199,303
| -2% | -$8.83M | 0.59% | 28 |
|
|
2021
Q2 | $359M | Buy |
9,168,873
+75,825
| +0.8% | +$2.95M | 0.45% | 46 |
|
|
2021
Q1 | $329M | Buy |
9,093,048
+2,137,550
| +31% | +$75.9M | 0.43% | 46 |
|
|
2020
Q4 | $256M | Sell |
6,955,498
-2,121,823
| -23% | -$77.8M | 0.36% | 50 |
|
|
2020
Q3 | $313M | Buy |
9,077,321
+4,177,316
| +85% | +$146M | 0.5% | 37 |
|
|
2020
Q2 | $152M | Sell |
4,900,005
-1,814,446
| -27% | -$61.6M | 0.28% | 72 |
|
|
2020
Q1 | $220M | Sell |
6,714,451
-2,777,234
| -29% | -$94.6M | 0.47% | 40 |
|
|
2019
Q4 | $353M | Sell |
9,491,685
-695,124
| -7% | -$24.8M | 0.57% | 34 |
|
|
2019
Q3 | $350M | Buy |
10,186,809
+539,095
| +6% | +$19.6M | 0.62% | 30 |
|
|
2019
Q2 | $397M | Sell |
9,647,714
-1,124,472
| -10% | -$44.7M | 0.72% | 25 |
|
|
2019
Q1 | $434M | Buy |
10,772,186
+321,818
| +3% | +$12.9M | 0.77% | 22 |
|
|
2018
Q4 | $433K | Sell |
10,450,368
-959,749
| -8% | -$39.8M | 0.78% | 19 |
|
|
2018
Q3 | $477M | Sell |
11,410,117
-1,703,424
| -13% | -$65.6M | 0.82% | 20 |
|
|
2018
Q2 | $452M | Sell |
13,113,541
-273,588
| -2% | -$9.35M | 0.79% | 18 |
|
|
2018
Q1 | $451M | Sell |
13,387,129
-843,639
| -6% | -$29M | 0.78% | 16 |
|
|
2017
Q4 | $489M | Buy |
14,230,768
+481,479
| +4% | +$16.4M | 0.8% | 16 |
|
|
2017
Q3 | $464M | Sell |
13,749,289
-1,416,385
| -9% | -$45.5M | 0.81% | 15 |
|
|
2017
Q2 | $484M | Sell |
15,165,674
-3,477,765
| -19% | -$110M | 0.87% | 14 |
|
|
2017
Q1 | $608M | Sell |
18,643,439
-656,288
| -3% | -$20.7M | 1.09% | 10 |
|
|
2016
Q4 | $595M | Sell |
19,299,727
-856,018
| -4% | -$26.1M | 1.14% | 7 |
|
|
2016
Q3 | $648M | Sell |
20,155,745
-1,111,768
| -5% | -$37.2M | 1.21% | 6 |
|
|
2016
Q2 | $710M | Sell |
21,267,513
-2,154,403
| -9% | -$68.8M | 1.43% | 2 |
|
|
2016
Q1 | $668M | Sell |
23,421,916
-2,227,314
| -9% | -$63.6M | 1.38% | 4 |
|
|
2015
Q4 | $786M | Sell |
25,649,230
-1,311,789
| -5% | -$41.3M | 1.62% | 3 |
|
|
2015
Q3 | $803M | Sell |
26,961,019
-423,455
| -2% | -$13.6M | 1.7% | 2 |
|
|
2015
Q2 | $873M | Buy |
27,384,474
+703,573
| +3% | +$22.9M | 1.72% | 2 |
|
|
2015
Q1 | $874M | Buy |
26,680,901
+9,342,300
| +54% | +$297M | 1.71% | 2 |
|
|
2014
Q4 | $512M | Sell |
17,338,601
-904,387
| -5% | -$25.9M | 1.01% | 7 |
|
|
2014
Q3 | $512M | Buy |
18,242,988
+559,453
| +3% | +$15.7M | 0.68% | 29 |
|
|
2014
Q2 | $498M | Buy |
17,683,535
+2,483,388
| +16% | +$70.8M | 0.62% | 27 |
|
|
2014
Q1 | $463M | Buy |
15,200,147
+372,135
| +3% | +$11.1M | 0.52% | 40 |
|
|
2013
Q4 | $431M | Sell |
14,828,012
-1,716,833
| -10% | -$50M | 0.54% | 35 |
|
|
2013
Q3 | $451M | Sell |
16,544,845
-5,636,844
| -25% | -$153M | 1.09% | 7 |
|
|
2013
Q2 | $589M | Buy |
+22,181,689
| New | +$613M | 1.56% | 2 |
|
Other funds holding PFE
Schroder Investment Management Group's PFE Position: Q2 2026 in Review
Schroder Investment Management Group increased its Pfizer (PFE) stake by 2.4% in Q2 2026, buying an estimated $7.86M and bringing the position to 12,896,296 shares worth $311M. The position accounts for 0.22% of the portfolio, ranked #97.
Schroder Investment Management Group first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $874M in Q1 2015. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Schroder Investment Management Group held 12,896,296 shares of Pfizer worth $311M as of Q2 2026.
- Schroder Investment Management Group bought 300,462 Pfizer shares in Q2 2026, an estimated $7.86M.
- Pfizer made up 0.22% of Schroder Investment Management Group's portfolio in Q2 2026, its #97 holding.
- Schroder Investment Management Group first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Schroder Investment Management Group's Pfizer position peaked at $874M in Q1 2015.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.